Comparation of Bioavailability: Two Dexlansoprazole Formulations in Beagle Dogs after a Single Dose Administration
Abstract
The study was performed to determine oral bioequivalence of generic dexlansoprazole and reference formulation (Dexilant) in healthy dogs.A 2 period crossover balanced design was used with a 7 days washout period between the doses.Dexlansoprazole was analyzed by LC-MS/MS in the presence of omeprazole as internal standard.The mean ratio of parameters C max and AUC 0-t and 90% confidence intervals of correspondents were calculated to determine the bioequivalence.The means AUC 0-t for test and reference formulation were 4094.5 ug/L*h and 3684.9 ug/L*h, for AUC 0-∞ were 4137.5 ug/L*h and 3709.6 ug/L*h and, for C max 1643.0 ug/L and 1498.2 ug/L, respectively.Geometric mean of the test /reference Pharmaceuticals 30 mg formulation individual percent ratio was 99.3% for AUC 0-t , 100.6% for AUC 0-∞ and 110.0% for C max .The 90% confidence intervals were 84.0%~ 117.5%, 85.3% ~ 118.7%, 85.0% ~ 142.3%, respectively.It was concluded that pharmacokinetic data for test formulation were similar enough to original innovator, both formulations had the delayed releasing and double peak characteristics in dogs according to the rate and extent of absorption.
Read the paper
Related studies
- Improving sleep quality leads to better mental health: A meta-analysis of randomised controlled trials
- Tocilizumab in patients with severe COVID-19: a retrospective cohort study
- A new aging measure captures morbidity and mortality risk across diverse subpopulations from NHANES IV: A cohort study
- Fruit, vegetable, and legume intake, and cardiovascular disease and deaths in 18 countries (PURE): a prospective cohort study
- Are noise and air pollution related to the incidence of dementia? A cohort study in London, England
- Long COVID symptoms and duration in SARS-CoV-2 positive children — a nationwide cohort study
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.